Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.

about

HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Research gaps in viral hepatitis.

P2860

Q39425755-00E72D3F-9292-49FE-82B1-2054E739404E Q52597010-302E7889-67E9-49D4-A5F1-2D40A6D1295D

P2860

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.

Item

http://www.wikidata.org/entity/Q40590338

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intensification with pegylated ...... B virus co-infected patients.

@en

type

Item

label

Intensification with pegylated ...... B virus co-infected patients.

@en

prefLabel

Intensification with pegylated ...... B virus co-infected patients.

@en

P1476

Intensification with pegylated ...... B virus co-infected patients.

@en

P2093

A Boyd

http://www.w3.org/2001/XMLSchema#string

C Bouix

http://www.w3.org/2001/XMLSchema#string

C Delaugerre

http://www.w3.org/2001/XMLSchema#string

C Lascoux-Combe

http://www.w3.org/2001/XMLSchema#string

F Lebossé

http://www.w3.org/2001/XMLSchema#string

K Lacombe

http://www.w3.org/2001/XMLSchema#string

L Piroth

http://www.w3.org/2001/XMLSchema#string

M Maynard-Muet

http://www.w3.org/2001/XMLSchema#string

N Mahjoub

http://www.w3.org/2001/XMLSchema#string

P Miailhes

http://www.w3.org/2001/XMLSchema#string

P2860

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.

Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis.

Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

HIV and viral hepatitis coinfections: advances and challenges.

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus.

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.

P304

1017-1026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12581

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabrice Carrat

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27486094

http://www.w3.org/2001/XMLSchema#string

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.

about

P2860

P2860

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698